CHEMOMAB THERAPEUTICS LTD (CMMB)
US16385C1045 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.22M | -27.65M | -12.48M | -5.95M | -27.12M | |||
| Depreciation Amortization | 67.00K | 60.00K | 30.00K | 20.00K | 280.00K | |||
| Change In Working Capital | -211.00K | 3.10M | -2.16M | 360.00K | 4.66M | |||
| Taxes Paid | -187.00K | -350.00K | N/A | N/A | N/A | |||
| Other non cash items | 754.00K | 4.12M | 2.23M | 320.00K | 5.73M | |||
| OPERATING CASH FLOW | -23.61M | -20.37M | -12.37M | -5.24M | -16.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.00K | -70.00K | -240.00K | -40.00K | -100.00K | |||
| Other Investing Activity | 15.88M | 19.60M | -44.95M | -20.00K | 0.00 | |||
| INVESTING CASH FLOW | 15.88M | 19.53M | -45.19M | -60.00K | -100.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 3.50M | 410.00K | 58.65M | 3.50M | 30.50M | |||
| Other Financing Activity | 0.00 | -1.22M | 2.43M | 1.25M | -3.88M | |||
| FINANCING CASH FLOW | 3.50M | -810.00K | 61.07M | 4.75M | 26.62M | |||
| CHANGE IN CASH | -4.23M | -1.65M | 3.51M | -550.00K | 10.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.61M | -20.37M | -12.37M | -5.24M | -16.46M | |||
| Capital Expenditure | -3.00K | -70.00K | -240.00K | -40.00K | -100.00K | |||
| FREE CASH FLOW | -23.61M | -20.44M | -12.61M | -5.28M | -16.56M | |||
All data in USD